Anteris Technologies Investor Presentations

Press Releases
Financials
Presentations
Governance
- Leadership Team
- Policies & Charters
Resources

Menu

Press Releases
Financials
Presentations
Governance
- Leadership Team
- Policies & Charters
Resources

Investor Presentations

Financial Filings Anteris Technologies

Investors
Investor Presentations

Previous AGM CEO Presentations

May 2024

May 2023

THIS WEBSITE USES COOKIES

We use cookies to enhance your browsing experience and analyze site traffic. By clicking "Accept," you consent to our use of cookies. For more information, please read our Privacy Policy

Subscribe to our newsletter and stay up to date on features and releases.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

Product

Home
Technology
About
News
Clinical Data
Careers
Contact

Investors

Investor Center
Press Releases
SEC/ASX Filings
Corporate Governance
Leadership Team
Financial Information
Investor Presentations

DurAVR® INVESTIGATIONAL USE ONLY. NOT AVAILABLE FOR COMMERCIAL SALE. EU: Exclusively for clinical investigations.

US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.

© 2024 Anteris Technologies. All rights reserved.

Privacy Policy